Chondroitin sulfate proteoglycan 4 and its potential as an antibody immunotherapy target across different tumor types
Ilieva, K. M., Cheung, A., Mele, S., Chiaruttini, G., Crescioli, S., Griffin, M., Nakamura, M., Spicer, J. F., Tsoka, S., Lacy, K. E., Tutt, A. N. J. & Karagiannis, S. N., 10 Jan 2018, In: Frontiers in Immunology. 8, JAN, p. 1911 15 p., 1911.
Research output: Contribution to journal › Review article › peer-review